A team of researchers from UCLA and the University of Toronto have identify a new biomarker found in urine; that can help detect aggressive prostate cancer, potentially saving hundreds of thousands of men each year; from undergoing unnecessary surgeries and radiotherapy treatments. Prostate cancer can be easy to diagnose, but classifying patients into risk groups…
A new study from researchers at the University of Michigan Rogel Cancer Center finds; that the gene FOXA1 overrides normal biology in three different ways to drive prostate cancer. They refer to the three classes as fast, furious, and loud to reflect their unique features. The findings are publish in Nature. The Fast and the…
Broader monitoring of patients is needed to reduce the number of people who develop a urinary tract infection; after being discharge from the hospital, new research by Oregon State University suggests. Findings were publish in the journal Infection Control & Hospital Epidemiology. The exploratory study of more than 3,000 at-risk patients show that infection; was…
Researchers have developed a new urine test to diagnose aggressive forms of prostate cancer; which could mean an end to the unnecessary treatment of men with non-aggressive cancers. The test, which has been develop by researchers at the University of East Anglia and Norfolk and Norwich University Hospital; would allow doctors to differentiate between patients…
Benign prostatic hyperplasia (BPH) is a common disease in men representing a substantial disease burden. BPH is characterised by a proliferation of both the stromal and epithelial cells of the prostate in the transitional zone surrounding the urethra.Approximately 50% of men >50 years of age have pathological evidence of BPH, increasing to >80% as men reach their eighth…
The aim of study was to investigate the link between chronic inflammation and risk of prostate cancer; by examining the association between 1) history of CIDs, and 2) use of AIMs, and prostate cancer incidence; using population-wide registry-based data. Our a priori hypotheses were that risk of prostate cancer would be increase; among men with…
Prostate cancer is the most commonly diagnose cancer and the second leading cause of cancer death in American men. Despite high response rates to initial androgen deprivation therapy; but in most of the patients with advanced disease will progress to metastatic castration‐resistant prostate cancer (mCRPC). First‐line treatments for mCRPC include targeting the androgen receptor (AR)…
World Trade Center (WTC) responders with prostate cancer show signs that exposure to dust; from the World Trade Center site had activate chronic inflammation in their prostates, which may have contributed to their cancer; according to a study by Mount Sinai researchers in Molecular Cancer Research in June. Inflammation has long been considered an important factor…
3-D printing can help for the identification of lesions and their correlation with surrounding structures, among other uses, prior to urological surgery, researchers report. In a paper online May 18 in European Urology, Dr. Giovanni E. Cacciamani of the University of Southern California, Los Angeles, and colleagues review the impact of 3D printing for surgical…
A“strong evidence” the link between obesity and the risk of advanced prostate cancer; classifies The World Cancer Research Fund . In light of the different hormonal profiles associate with where adipose is store; this study investigate the role of objectively measure body fat distribution and the risk of prostate cancer. In the first prospective study…
Cardiovascular health and physical activity levels of prostate cancer patients improve following successful interventions by community pharmacies, new research reports. In the first study of its kind, researchers from the University of Surrey, fund by the Movember Foundation in partnership with Prostate Cancer UK; develop and test the feasibility of community pharmacies delivering program to…
Prostate Cancer; Mortality due to prostate cancer is usually relate to its likelihood to metastasize, especially to bone. Prognostic biomarkers are urgently need to predict disease aggression so that appropriate treatment can be selected. A report in The American Journal of Pathology, publish by Elsevier, indicates that CCN3, a protein secret into the extracellular matrix…